It may have seemed like an…
It may have seemed like an ordinary Wednesday afternoon at [...]
Luma Group announced the final…
Luma Group announced the final close of its inaugural life [...]
Neuro-focused Encoded Therapeutics…
Neuro-focused Encoded Therapeutics has bagged a $275 million series F [...]
Tyra Biosciences has reported…
Tyra Biosciences has reported initial phase 2 data on dabogratinib [...]
With a detailed data drop that…
With a detailed data drop that AstraZeneca’s R&D chief describes [...]
Spyre’s three-pronged approach to…
Spyre’s three-pronged approach to inflammatory bowel disease continues to pay [...]
Pharvaris’ deucrictibant has…
Pharvaris’ deucrictibant has tasted success in a second phase 3 [...]
Novo Nordisk has given up on two…
Novo Nordisk has given up on two more phase 3 [...]
ADARx has reinvigorated its…
ADARx has reinvigorated its ambitions to go public as the [...]
Novartis’ Ionis-partnered drug…
Novartis’ Ionis-partnered drug designed to lower levels of Lp(a), a [...]